• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A new therapeutic strategy using adenovirus vector REIC gene in a new glioblastoma (GBM) mice model

Research Project

Project/Area Number 23592128
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Cerebral neurosurgery
Research InstitutionThe University of Tokushima

Principal Investigator

KAGEJI Teruyoshi  徳島大学, 大学病院, 特任教授 (70294684)

Co-Investigator(Kenkyū-buntansha) MIZOBUCHI Yoshifumi  徳島大学, 大学院ヘルスバイオサイエンス研究部, 助教 (80547993)
NAGAHIRO Shinji  徳島大学, 大学院ヘルスバイオサイエンス研究部, 教授 (60145315)
MURE Hideo  徳島大学, 病院, 助教 (00624355)
KURASHIKI Yoshitaka  徳島大学, 病院, 特任助教 (10597503)
Project Period (FY) 2011 – 2013
Project Status Completed (Fiscal Year 2013)
Budget Amount *help
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥130,000 (Direct Cost: ¥100,000、Indirect Cost: ¥30,000)
Fiscal Year 2012: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
Fiscal Year 2011: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Keywords脳腫瘍 / REIC / Wntシグナル / 薬物排出ポンプ / REIC/Dkk-3 / アポトーシス / glioblastoma / Wnt シグナル
Research Abstract

Glioblastoma multiform (GBM) remains incurable despite the use of aggressive and multimodal therapies involving tumor resection, chemotherapy and radiation therapy. The cancer stem cell theory postulates that tumors are sustained by a select cell population with self-renewal ability and the capacity to give rise to a heterogeneous mass of tumor cells. Based on the existence of glioma stem cells for glioblastoma, Saya et al. established the new GBM model. Elsewhere we demonstrated that Dickkopf family3 (DKK3) was down-regulated in GBM cells and that its over-expression drastically inhibited their growth via caspase-dependent apoptosis. The aim of our study was 1) to establish this model in our institute and 2) to assess the efficacy of Ad-DKK3 in the GBM mice model and 3) to verify the mechanisms underlying the efficacy of DKK3. We partly verified the mechanisms underlying the efficacy by DKK3 in GBM and submitted our paper to Cancer Letter.

Report

(4 results)
  • 2013 Annual Research Report   Final Research Report ( PDF )
  • 2012 Research-status Report
  • 2011 Research-status Report
  • Research Products

    (14 results)

All 2014 2013 2012

All Journal Article (6 results) (of which Peer Reviewed: 6 results) Presentation (8 results)

  • [Journal Article] Nine-year interval recurrence after treatment of boron neutron capture therapy in a patient with glioblastoma2014

    • Author(s)
      Okazaki T, Kageji T, Mizobuchi Y, Miyamoto T, Nagahiro S
    • Journal Title

      A case report. Appl Radiat Isot

      Volume: 88 Pages: 28-31

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT)2014

    • Author(s)
      Kageji T, Mizobuchi Y, Nagahiro S, Nakagawa Y, Kumada H
    • Journal Title

      Appl Radiat Isot

      Volume: 88 Pages: 20-22

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Nine-year interval recurrence after treatment of boron neutron capture therapy in a patient with glioblastoma: A case report2014

    • Author(s)
      Toshiyuki Okazaki, Teruyoshi Kageji, Yoshifumi Mizobuchi, Takeshi Miyamoto, Shinji Nagahiro
    • Journal Title

      Appl Radiat Isot

      Volume: S0969-8043(13) Pages: 629-5

    • Related Report
      2013 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Differential diagnosis of and therapy for anaplastic astroblastoma : case report and review of the literature]2013

    • Author(s)
      Kurashiki Y, Kageji T, Mizobuchi Y, Satomi J, Satoh K, Hirose T, Nagahiro S
    • Journal Title

      No Shinkei Geka

      Volume: 41 Pages: 891-899

    • Related Report
      2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT)2013

    • Author(s)
      Kageji T, T. Kageji, Y. Mizobuchi, S. Nagahiro, Y. Nakagawa, H. Kumada
    • Journal Title

      Appl Radiat Isot

      Volume: S0969-8043(13) Pages: 610-6

    • Related Report
      2013 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Anaplastic astroblastomaの鑑別診断と治療 ー症例報告と文献的考察ー2013

    • Author(s)
      倉敷佳孝、影治照喜、溝渕佳史、里見淳一郎、佐藤浩一、廣瀬隆則、永廣信治
    • Journal Title

      脳神経外科

      Volume: 41 Pages: 891-899

    • Related Report
      2013 Annual Research Report
    • Peer Reviewed
  • [Presentation] Dkk-3, one of Dickkopf (Dkk) family members2013

    • Author(s)
      Hara K, Kageji T, Mizobuchi Y, Kitazato KT, Okazaki T, Fujihara T, Nakajima K, Mure H, Kuwayama K, Hara K, Nagahiro S
    • Organizer
      contributes to the anti-tumor effects in glioblastoma through regulation of both Wnt signal pathways SNO 2013
    • Place of Presentation
      Moscone West Convention Center (San Francisco, USA)
    • Related Report
      2013 Final Research Report
  • [Presentation] Down- regulation of MDR by Ad-Dkk3 contri- butes to augment the chemotherapy by temozolomide2013

    • Author(s)
      Nakajima K, Hara K, Kageji T, Mizobuchi Y, Kitazato KT, Fujihara T, Kuwayama K, Otsuka R, Kung DK, Nagahiro S
    • Organizer
      SNO 2013
    • Place of Presentation
      Moscone West Convention Center (San Francisco, USA)
    • Related Report
      2013 Final Research Report
  • [Presentation] A combination of interferon-b and temozolomide augments anti-tumor effects through p73/YAP-mediated apoptosis by PML in glioblastoma2013

    • Author(s)
      Mizobuchi Y, Okazaki T, Kageji T, Kuwayama K, Kitazato KT, Mure H, Hara K, Morigaki R, Matsuzaki K, Nakajima K, Fujihara T, Nagahiro S
    • Organizer
      SNO 2013
    • Place of Presentation
      Moscone West Convention Center (San Francisco, USA)
    • Related Report
      2013 Final Research Report
  • [Presentation] Dkk-3, one of Dickkopf (Dkk) family members, contributes to the anti-tumor effects in glioblastoma through regulation of both Wnt signal pathways2013

    • Author(s)
      K.Hara, T.Kageji, Y.Mizobuchi, K.T.Kitazato, T.Okazaki, T.Fujihara, K.Nakajima, H.Mure, K.Kuwayama, T.Hara, S.Nagahiro
    • Organizer
      SNO 2013
    • Place of Presentation
      Marriott Maquis Hotel (San Francisco, USA)
    • Related Report
      2013 Annual Research Report
  • [Presentation] Down-regulation of MDR by Ad-Dkk3 contributes to augment the chemotherapy by temozolomide2013

    • Author(s)
      K.Nakajima, K.Hara, T.Kageji, Y.Mizobuchi, K.T.Kitazato, T.Fujihara, K.Kuwayama, R.Otsuka, D K.Kung, S.Nagahiro
    • Organizer
      SNO 2013
    • Place of Presentation
      Marriott Maquis Hotel (San Francisco, USA)
    • Related Report
      2013 Annual Research Report
  • [Presentation] A combination of interferon-b and temozolomide augments anti-tumor effects through p73/YAP-mediated apoptosis by PML in glioblastoma2013

    • Author(s)
      Y.Mizobuchi, T.Okazaki, T.Kageji, K.Kuwayama, K.T.Kitazato, H.Mure, K.Hara, R.Morigaki, K.Matsuzaki, K.Nakajima, T.Fujihara, S.Nagahiro
    • Organizer
      SNO 2013
    • Place of Presentation
      Marriott Maquis Hotel (San Francisco, USA)
    • Related Report
      2013 Annual Research Report
  • [Presentation] 悪性神経膠腫におけるREIC/Dkk-3遺伝子導入によるWnt蛋白制御の意義2012

    • Author(s)
      原慶次郎、溝渕佳史、北里慶子、岡﨑敏之、影治照喜、永廣信治、公文裕巳
    • Organizer
      第13回日本分子脳神経外科学会
    • Place of Presentation
      熊本市国際交流会館(熊本県熊本市)
    • Related Report
      2013 Final Research Report
  • [Presentation] 悪性神経膠腫におけるREIC/Dkk-3遺伝子導入によるWnt蛋白制御の意義2012

    • Author(s)
      原慶次郎他
    • Organizer
      第13回日本分子脳神経外科学会
    • Place of Presentation
      熊本市国際交流会館(熊本県)
    • Related Report
      2012 Research-status Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi